BYHEALTH cites tough market conditions for nearly 18% revenue decline By Tingmin Koe 03-Sep-2024 - Last updated on 03-Sep-2024 at 06:09 GMT Facebook Twitter Linkedin Email to a friend China dietary supplement giant BYHEALTH's revenue in the first half of 2024 fell nearly 18 per cent, which it said was mainly due to the changing consumption landscape and stiff market competition. Read the full story here. NIA top stories monthly “This is the year of innovation for China”: Danone to beef up infant formula, FSMP range Hong Kong nutra trends: NMN booming and strategies to meet local and Chinese visitors’ needs Novel format, celebrity push, and German branding key for Korea success – Orthomol BYHEALTH cites tough market conditions for nearly 18% revenue decline Sleep, mental health underlined as top-of-mind concerns among APAC consumers amid cost-of-living crisis Fonterra delves deeper into protein and phospholipids for mobility-related innovations to combat Asia’s ageing population Calcium supplements: China consumers resonate strongly with absorption benefits, says Haleon NMN measurements: China drafts industry standards to assess cross-border e-commerce products 'Proof on the front': Indian start-up ReNewtra adopts front-of-pack labelling as concerns over transparency grow Kirin plans to acquire another overseas asset if FANCL deal fails Prev 1 … 3 4 5 6 7 … 11 Next
